Myocardial matrix hydrogel acts as a reactive oxygen species scavenger and supports a proliferative microenvironment for cardiomyocytes is a research paper published in Acta Biomaterialia (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
California Institute for Regenerative Medicine
Grant: FA1-00607
National Heart, Lung, and Blood Institute
Grant: 1F31HL158212
National Heart, Lung, and Blood Institute
Grant: F31HL137347
National Heart, Lung, and Blood Institute
Grant: R01HL113468
National Heart, Lung, and Blood Institute
Grant: R01HL146147
National Heart, Lung, and Blood Institute
Grant: R01HL165232
National Heart, Lung, and Blood Institute
Grant: T32HL105373
NIH HHS
Grant: S10 OD021641
National Institutes of Health
Grant: 2T32HL105373-06A1
Integrative Bioengineering of Heart, Vessels, and Blood
National Institutes of Health
Grant: 1F31HL158212-01A1
Investigation of a Right Ventricle Based Decellularized Extracellular Matrix Hydrogel and Cardiac Progenitor Cells as a Treatment for Right Ventricular Heart Failure
National Institutes of Health
Grant: 5F31HL137347-02
Investigating Whether Myocardial Matrix Therapy Induces New Cardiomyocyte Formation Following Myocardial Infarction
National Institutes of Health
Grant: 3R01HL113468-03S1
Extracellular matrix hydrogels for treating ischemia
National Institutes of Health
Grant: 5R01HL165232-04
Infusible Extracellular Matrix for Treating Myocardial Infarction
National Institutes of Health
FWCI
6.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals